Victoria L. Chiou

Pseudoprogression and Immune-Related Response in Solid Tumors

Victoria L. Chiou, Mauricio Burotto · Journal of Clinical Oncology · 2015 · 909 citations

Life Sciences, Immunology, Oncology +17

Sequence-Specific Pharmacokinetic and Pharmacodynamic Phase I/Ib Study of Olaparib Tablets and Carboplatin in Women's Cancer

Jung Min Lee, Cody J. Peer, Minshu Yu et al. · Clinical Cancer Research · 2016 · 59 citations · Full text

Medicine, Oncology, Pharmacology +16

Phase I/Ib study of olaparib and carboplatin in women with triple negative breast cancer

Jung Min Lee, John L. Hays, Victoria L. Chiou et al. · Oncotarget · 2017 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I study of the PD-L1 inhibitor, durvalumab (MEDI4736; D) in combination with a PARP inhibitor, olaparib (O) or a VEGFR inhibitor, cediranib (C) in women's cancers (NCT02484404).

Jung‐Min Lee, Alexandra Dos Santos Zimmer, Stan Lipkowitz et al. · Journal of Clinical Oncology · 2016 · 30 citations

Medicine, Oncology, Pharmacology +17

Safety and clinical activity of MEDI0562, a humanized OX40 agonist monoclonal antibody, in adult patients with advanced solid tumors

Bonnie S. Glisson, Rom S. Leidner, Robert L. Ferris et al. · Annals of Oncology · 2018 · 22 citations · Full text

Medicine, Oncology, Pharmacology +17